[1]史 毅 邓剑平 李 江 赵振伟.Wingspan支架治疗症状性大脑中动脉狭窄的安全性和有效性[J].中国临床神经外科杂志,2015,(10):609-611.[doi:10.13798/j.issn.1009-153X.2015.10.010]
 SHI Yi,DENG Jian-ping,LI Jiang,et al.Curative effect of Wingspan stents system on symptomatic middle cerebral arterial stenosis and its safety[J].,2015,(10):609-611.[doi:10.13798/j.issn.1009-153X.2015.10.010]
点击复制

Wingspan支架治疗症状性大脑中动脉狭窄的安全性和有效性()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2015年10期
页码:
609-611
栏目:
论著
出版日期:
2015-10-30

文章信息/Info

Title:
Curative effect of Wingspan stents system on symptomatic middle cerebral arterial stenosis and its safety
文章编号:
1009-153X(2015)10-0609-03
作者:
史 毅 邓剑平 李 江 赵振伟
710028 西安,第四军医大学唐都医院神经外科
通讯作者:赵振伟,E-mail:zzwzc@sina.com
Author(s):
SHI Yi DENG Jian-ping LI Jiang ZHAO Zhen-wei.
Department of Neurosurgery, Tangdu Hospital, The Fourth Military Medical University, PLA , Xi’an 710038, China
关键词:
症状性大脑中动脉狭窄Wingspan支架血管内支架成形术疗效
Keywords:
Wingspan stent Middle cerebral artery Stenosis Angioplasty
分类号:
R 743; R 815.2
DOI:
10.13798/j.issn.1009-153X.2015.10.010
文献标志码:
A
摘要:
目的 探讨Wingspan支架治疗症状性大脑中动脉狭窄的有效性、安全性。方法 回顾性分析116例症状性大脑中动脉狭窄患者的临床资料,均采用Wingspan支架治疗。结果 116例患者均支架置入顺利,手术成功率为100%,术前狭窄率为(72.1±9.4)%,术后即刻残留狭窄率为(21.4±14.8)%;围手术期发生脑血管相关并发症5例(4.3%),死亡1例(0.9%);临床随访67例患者,随访时间为43.9(19~88)个月,再发缺血性并发症4例(6.0%);影像学随访51例患者,随访时间为9.1(2~36)个月,发现支架内再狭窄7例(13.7%),其中症状性再狭窄2例(3.9%)。结论 Wingspan支架治疗症状性大脑中动脉狭窄是安全、有效的。
Abstract:
Objective To study the Efficacy and safety of treatment of symptomatic middle cerebral arterial stenosis (MCAS)with Wingspan stents. Methods The clinical data of 116 patients with MCAS treated with Wingspan stents were analyzed retrospectively, including patients characteristics, clinical manifestations, treatment, imaging data and following up data and so on. Results Wingspan stents were successfully implanted in all the patients. The mean degree of stenosis was decreased from preoperative (72.1±9.4)% to postoperative (21.4±14.8)%. There were peri-procedural complications in 5 (4.3%) patients. One patient died. There were recurrent ischemic events in 4 (6.0%) of 67 patients who were clinically followed up from 19 to 88 months (mean, 43.9 months). The intra-stent restenoses occurred in 7 (13.7%) and the symptomatic restenoses in 2 (3.9%) of 51 patients who were followed up by imaging from 2 to 36 months (mean, 9.1 months). Conclusions The treatment of MCAS with Wingspan stents is safe and effective, but the individualized treatment tactics should be selected.

参考文献/References:

[1] Feldmann E, Daneault N, Kwan E, et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease [J]. Neurology, 1990, 40(10): 1541-1545.
[2] Huang YN, Gao S, Li SW, et al. Vascular lesions in Chinese patientss with transient ischemic attacks [J]. Neurology, l997, 48(2): 514 -525.
[3] Wang KS, Huang YN, Gao S, et al. Intracranial stenosis in Chinese patients with acute stroke [J]. Neurology, 1998 , 50 (3): 812-813.
[4] Li H, Wong KS. Racial distribution of intracranial atheros- clerosis [J]. Clin Neurosci 2002, 10: 30-34.
[5] Chimowltz MJ, Lynn MJ, Howler-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intraeranial arterial stenosis [J]. N Engl J Med, 2005, 352(13): 1305-1316.
[6] Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis the vissit randomized clinical trial [J]. JAMA, 2015, 313(12): 1240-1248.
[7] Kurre W, Berkefeld J, Brassel F, et al. In-hospital compli- cation rates after stent treatment of 388 symptomatic intrae- ranial stenoses: results from the INTRASTENT multicentric registry [J]. Stroke, 2010, 41: 494-498.
[8] Marinkovic S, Milisavljevic M, Gibo H, et al. Microsurgical anatomy of the perforating branches of the vertebral artery [J]. Surg Neurol, 2004, 61(2): 190-197.
[9] Poemer TC, Kralev S, Voelker W, et al. Natural history of small and medium-sized side branches after coronary stent implantation [J]. Am Heart, 2002, 143(4): 627-635.
[10] Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial [J]. Lancet, 2014, 383 (9914): 333-3341.

相似文献/References:

[1]魏 恒 马江红 张 华 曹 敏 徐丽琴 曾静霞.Wingspan支架置入术治疗椎动脉狭窄的疗效观察[J].中国临床神经外科杂志,2015,(07):430.[doi:10.13798/j.issn.1009-153X.2015.07.017]
[2]王 冰 陈 虎 李 江 邓剑平 何宜轩 赵振伟.颅内前循环wingspan支架内再狭窄的危险因素分析[J].中国临床神经外科杂志,2021,26(06):419.[doi:10.13798/j.issn.1009-153X.2021.06.005]
 WANG Bing,CHEN Hu,LI Jiang,et al.Risk factors for in-stent restenosis after wingspan stenting in patients with atherosclerotic anterior circulation stenosis[J].,2021,26(10):419.[doi:10.13798/j.issn.1009-153X.2021.06.005]

更新日期/Last Update: 2015-10-30